Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma

Liposomes constitute one of the most popular nanocarriers for improving the delivery and efficacy of agents in cancer patients. The purpose of this study was to design and evaluate immunoliposome co-delivery of bufalin and anti-CD40 to induce synergetic therapeutic efficacy while eliminating systemi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Nanomedicine
Autori principali: Li, Ying, Yuan, Jiani, Yang, Qian, Cao, Wei, Zhou, Xuanxuan, Xie, Yanhua, Tu, Honghai, Zhang, Ya, Wang, Siwang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2014
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4260685/
https://ncbi.nlm.nih.gov/pubmed/25506218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S73651
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi